Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Non-Current Assets (2020 - 2024)

Immuneering (IMRX) has 5 years of Non-Current Assets data on record, last reported at $13.3 million in Q3 2024.

  • For Q3 2024, Non-Current Assets changed 0.0% year-over-year to $13.3 million; the TTM value through Sep 2024 reached $53.7 million, changed 0.06%, while the annual FY2023 figure was $13.5 million, 0.88% down from the prior year.
  • Non-Current Assets reached $13.3 million in Q3 2024 per IMRX's latest filing, down from $13.4 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $14.4 million in Q4 2021 and bottomed at $691799.0 in Q4 2020.
  • Average Non-Current Assets over 5 years is $11.6 million, with a median of $13.4 million recorded in 2023.
  • Peak YoY movement for Non-Current Assets: soared 1977.31% in 2021, then fell 5.22% in 2022.
  • A 5-year view of Non-Current Assets shows it stood at $691799.0 in 2020, then skyrocketed by 1977.31% to $14.4 million in 2021, then fell by 5.22% to $13.6 million in 2022, then fell by 0.88% to $13.5 million in 2023, then fell by 1.51% to $13.3 million in 2024.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were $13.3 million in Q3 2024, $13.4 million in Q2 2024, and $13.5 million in Q1 2024.